Biotech Blog Archives: July 2003
·
previous page
7 July 2003
Antibacterials: a dying trade
Antibacterials: a dying trade
: Despite strong worldwide demand for effective antibacterial products, sustaining growth within this segment will become a challenging task for major pharmaceutical companies. Currently only six marketed drugs have sales of greater than $1 billion and by 2011, 12 out of 29 key products will face patent expiry. A relatively sparse R&D [...]
continue reading... » 0 Comments
7 July 2003
Financial Snapshot For June 2003: Taking A Breather
Financial Snapshot For June 2003: Taking A Breather
continue reading... » 0 Comments
3 July 2003
Pfizer’s Quest to Stay Ahead of the Pack
Pfizer’s Quest to Stay Ahead of the Pack
The drugmaker has been a stable holding in unstable times. Now, though, it faces big challenges from rivals to its Lipitor and Viagra
continue reading... » 0 Comments
3 July 2003
Can Your Genomics Work Contribute to Biodefense
Can Your Genomics Work Contribute to Biodefense
Three years ago, Luis Villarreal, a virologist at the University of California, Irvine, came up with the idea of using in vitro gene activation by PCR to study the proteome of a virus in hopes of developing a high-throughput platform for identifying new vaccines.
Villarreal and his collaborators at the [...]
